Clinical Trial Update: Diagnostic Accuracy and Performance of 18F-PSMA-1007

View source ↗

Summary

A completed clinical trial evaluating the diagnostic accuracy and performance of the radiotracer 18F-PSMA-1007 for detecting prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA-1007 (PSMA-1007 radiotracer)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Prostate Cancer | Status: COMPLETED